CureVac's market cap is currently €821.61M. The company's EPS TTM is €-0.07; its P/E ratio is 6.19; CureVac is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
